Sign In
Buy CODX
$5.17
-1.05 (-16.88%)
At Close: Jun 03, 2026
A+ Top Quant Rated Healthcare Stocks For Value, Growth, And Profitability
08:38am, Wednesday, 23'rd Dec 2020
Three referenced quant rating categories (value, growth, and profitability) are significant considerations in selecting healthcare investments. The data underlying the value, growth, and profitability
These 5 Small-Cap Healthcare Stocks Gained the Most in 2020
06:55am, Wednesday, 23'rd Dec 2020
These stocks have made investors richer by posting explosive revenue growth or advancing significantly in high-impact programs.
These Were the 10 Best Healthcare Stocks of 2020
06:35am, Tuesday, 15'th Dec 2020
The highest performers of the year are biotechs fighting COVID-19 and cancer. Are they still buys for 2021?
Co-Diagnostics Announces Milestone of Over 10 Million COVID-19 Tests Sold
09:30am, Monday, 14'th Dec 2020
SALT LAKE CITY, Dec. 14, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular dia
Up 1,000% in 2020, Is Co-Diagnostics Stock Still a Buy?
12:44pm, Thursday, 10'th Dec 2020
The company has unbelievable top-line growth right now, and has profit margins over 60%. Will the stock continue to ride high once the world is vaccinated?
Why Co-Diagnostics Stock Jumped Today
03:40pm, Wednesday, 25'th Nov 2020
The company's joint venture in India received good news.
Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test
01:00pm, Wednesday, 25'th Nov 2020
SALT LAKE CITY, Nov. 25, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular dia
Why Co-Diagnostics Stock Is Getting Clobbered Today
12:18pm, Tuesday, 17'th Nov 2020
The company badly missed Wall Street earnings estimate for the third quarter.
Co-Diagnostics, Inc. Receives CE Markings for "ABC" and SARS-CoV-2 2-Gene Multiplex Tests
06:30am, Tuesday, 17'th Nov 2020
SALT LAKE CITY, Nov. 17, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, a
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q3 2020 Results - Earnings Call Transcript
10:06pm, Monday, 16'th Nov 2020
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q3 2020 Results - Earnings Call Transcript
The Virus Testing Stocks Pullback Opportunity (NASDAQ: CODX) (NASDAQ: FLGT) (OTC: ALST) (NYSE: LH)
08:21am, Wednesday, 11'th Nov 2020
The Virus Testing Stocks Pullback Opportunity (NASDAQ: CODX) (NASDAQ: FLGT) (OTC: ALST) (NYSE: LH)
Co-Diagnostics, Inc. CoPrimers™ Shown to be Effective in COVID-19 Saliva PCR Tests Without Sample Extraction
06:30am, Wednesday, 11'th Nov 2020
SALT LAKE CITY, Nov. 11, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, a
Co-Diagnostics, Inc. Announces Q3 2020 Earnings Release Date and Earnings Webcast
06:30am, Tuesday, 10'th Nov 2020
SALT LAKE CITY, Nov. 10, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, a
Co-Diagnostics, Inc. to Amend Q2 2020 Form 10-Q to Show $0.51 Net Income per Share
04:45pm, Monday, 02'nd Nov 2020
SALT LAKE CITY, Utah, Nov. 2, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tes
Co-Diagnostics, Inc. Logix Smart Kit to be Used with Newly Authorized Saline Oral Rinse Collection
10:30am, Friday, 02'nd Oct 2020
SALT LAKE CITY, Oct. 2, 2020 /PRNewswire via COMTEX/ --
SALT LAKE CITY, Oct. 2, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular...
